| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |